Treatment of acquired myasthenia gravis

Neurology

Volumn 48, Issue 4 SUPPL. 5, 1997, Pages

  Massey, Janice M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; EDROPHONIUM CHLORIDE; IMMUNOGLOBULIN; NEOSTIGMINE; PREDNISONE;

CHOLINESTERASE INHIBITION; CONFERENCE PAPER; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MYASTHENIA GRAVIS; PLASMAPHERESIS; PRIORITY JOURNAL; STEROID THERAPY; THYMECTOMY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; WEIGHT GAIN;

EID: 0030907920     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.48.suppl_5.46s     Document Type: Conference Paper

References (30)

1. Oosterhuis HJGH. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989;52:1121-1127.
2. Jaretzki A, Wolff M. "Maximal" thymectomy for myasthenia gravis. Surgical anatomy and operative technique. J Thorac Cardiovasc Surg 1988;96:711-716.
3. Lanska DJ. Indications for thymectomy in myasthenia gravis. Neurology 1990;40:1828-1829.
4. Massey JM, Olanow, Howard JF, Sanders DB. Treatment of myasthenia gravis in the elderly [abstract]. Proc 7th Int Conf Myasthenia Gravis 1986.
5. Johns TR. Long-term corticosteroid treatment of myasthenia gravis. Ann NY Acad Sci 1987;505:568-583.
6. Pascuzzi RM, Coslett HB, Johns TR. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients. Ann Neurol 1984;15:291-298.
7. Witte AS, Cornblath DR, Schatz NJ, Lisak RP. Monitoring azathioprine therapy in myasthenia gravis. Neurology 1986; 36:1533-1534.
8. Confavreax C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G. Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 1996;46:1607-1612.
9. Myasthenia Gravis Clinical Study Group. A randomized clinical trial comparing prednisone and azathioprine in myasthenia gravis. Results of the second interim analysis. J Neurol Neurosurg Psychiatry 1993;56:1157-1163.
10. Goulon M, Elkharrat D, Gajdos P. Cyclosporine in patients with severe myasthenia gravis. Results of a 12 month open trial. Presse Med 1989;18:341-346.
11. Tindall RSA, Phillips JT, Rollins JA, Wells L, Hall K. A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann NY Acad Sci 1993;681:539-551.
12. Tindall RSA, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendiuk G. Preliminary results of a double-blind, randomized placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 1987;316:719-724.
13. Perez MC, Buot WL, Mercado-Danguilan C, Bagabaldo ZG, Renales LD. Stable remissions in myasthenia gravis. Neurology 1981;31:32-37.
14. Cosi V, Lombardi M, Piccolo G, et al. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin. Acta Neurol Scand 1991;84:81-84.
15. Fateh-Moghadam A, Wick M, Besinger U, et al. High dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984;1:848-849.
16. Gajdos PH, Outin H, Elkharrat D. High dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984;1:406-407.
17. Howard JF, Bowman MH, Sanders DB, Massey JM, Cook L. High dose gammaglobulin treatment in myasthenia gravis. Annual Scientific Session of the Myasthenia Gravis Foundation, 1985.
18. Vera-Ramirez M, Charlet M, Parry GA. Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 1992;42:1636-1637.
19. Tan E, Hajinazarian M, Bay W, et al. Acute renal failure resulting from intravenous immunoglobulin therapy. Arch Neurol 1993;50:137-139.
20. US Department of Health and Human Services. Outbreak of hepatitis C associated with intravenous immunoglobulin administration - United States, October 1993-June 1994. MMWR 1994;43:505-508.
21. Plauche WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol 1991;34:82-99.
22. Massey JM, Sanders DB. Single-fiber electromyography in myasthenia gravis during pregnancy. Muscle Nerve 1993;16: 458-460.
23. McNall PG, Jafarnia MR. Management of myasthenia gravis in the obstetrical patient. Am J Obstet Gynecol 1965;92:518.
24. Pitkin RM. Drugs in pregnancy. In: Quilligan EJ, Dretchmer N, eds. Fetal and maternal medicine. New York: John Wiley, 1989:396.
25. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990;99:443-446.
26. Haagsma EB, Visser GH, Klompmaker IJ, Verwer R, Slooff MJ. Successful pregnancy after orthotopic liver transplantation. Obstet Gynecol 1989;74:442-443.
27. Levine SE, Keesey JC. Successful plasmapheresis for fulminant myasthenia gravis during pregnancy. Arch Neurol 1986; 43:197-198.
28. Samuels P, Pfeifer SM. Autoimmune diseases in pregnancy. The obstetrician's view. Rheum Dis Clin North Am 1989;15: 307-322.
29. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci 1987;505:472-479.
30. Gorback MS, Moon RE, Massey JM. Extubation after transsternal thymectomy for myasthenia gravis: a prospective analysis. South Med J 1991;84:701-706.